National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- (-) Cancer (2)
- Cancer: Breast Cancer (1)
- Cancer: Ovarian Cancer (1)
- Comparative Effectiveness (1)
- (-) Evidence-Based Practice (2)
- Family Health and History (1)
- Genetics (1)
- Guidelines (1)
- Patient-Centered Outcomes Research (1)
- Prevention (1)
- Research Methodologies (1)
- Risk (1)
- Screening (1)
- U.S. Preventive Services Task Force (USPSTF) (1)
- Women (1)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 2 of 2 Research Studies DisplayedGerber DE, Pruitt SL, Halm EA
Should criteria for inclusion in cancer clinical trials be expanded?
The authors argue that the time is right to take a more evidence-based approach to assessing the validity of many traditional exclusion criteria for cancer clinical trials. Furthermore, for investigators, it is critically important that their selection of inclusion and exclusion criteria be thoughtful, deliberate and justified. To accomplish this, they will need to use an array of methodological approaches to assess their validity and impact.
AHRQ-funded; HS022418.
Citation: Gerber DE, Pruitt SL, Halm EA .
Should criteria for inclusion in cancer clinical trials be expanded?
J Comp Eff Res 2015;4(4):289-91. doi: 10.2217/cer.15.27..
Keywords: Evidence-Based Practice, Research Methodologies, Cancer, Comparative Effectiveness, Patient-Centered Outcomes Research
Nelson HD, Pappas M, Zakher B
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
This systematic review was done in support of the U.S. Preventive Services Task Force (USPSTF) updated recommendation on the benefit and harms of risk assessment, genetic testing, and genetic counseling for BRCA-related cancer in women. A systematic review was done on literature from 2004 to July 30, 2013 from MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Health Technology Assessment, Scopus, and reference lists. Data on the participants, study design, analysis, follow-up, and results was extracted and a second investigator confirmed key data. The studies were rated on study quality and applicability. The analysis found women with high-risk for breast cancer had decreased risk of breast cancer by 85% to 100% by having a mastectomy, and risk of mortality by 81% to 100% compared to women without surgery. There was also a lower risk of breast and ovarian cancer after having salpingo-oopherectomy surgery.
AHRQ-funded; 290200710057
Citation: Nelson HD, Pappas M, Zakher B .
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Ann Intern Med 2014 Feb 18;160(4):255-66. doi: 10.7326/m13-1684..
Keywords: U.S. Preventive Services Task Force (USPSTF), Cancer: Breast Cancer, Cancer: Ovarian Cancer, Cancer, Genetics, Screening, Prevention, Guidelines, Evidence-Based Practice, Women, Risk, Family Health and History